Augmentation of LAK induction from human peripheral blood mononuclear cells by N-CWS
β Scribed by Takuma Shirasaka; Ichiro Kawase; Misa Kitahara; Masaji Okada; Tomiya Masuno; Susumu Kishimoto; Yuichi Yamamura
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 70 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A wide variety of human cancers currently have no effective treatment and are potential targets for lymphokine-activated killer (LAK) cellular immunotherapy. Relapsed acute lymphocytic leukemia (ALL) and neuroblastoma are two of the major therapeutic challenges in pediatric oncology today. However,
Four calcium and phospholipid binding proteins purified from mononuclear cells were characterized for PKC and EGF phosphorylation, actin binding capacity, and partial tissue distribution. Those named 35K, 32K, and 73K are equivalent, respectively, to lipocortin III, endonexin II and the 67 kDa calel
In the rat, nerve growth factor (NGF) has been shown to affect immune reactivity by binding to cell surface receptors on a subpopulation of splenic mononuclear cells. This binding occurs in a specific and saturable fashion to what appear to be low-affinity (type 11) NGF receptors (NGFR). Immunofluor